| Bid price | 39.00 | Open price | 40.50 |
|---|---|---|---|
| Ask price | 42.00 | Prev close | 40.50 |
| High price | 0.00 | Spread | 7.14% |
| Low price | 0.00 | Volume | 0 |
Register now for FREE live PuriCore share prices, PuriCore stock quotes, charts, trades and FREE PuriCore company fundamentals, market news and much much more. Why not upgrade to a premium service and get PuriCore Level 2 Data, indepth research tools and investor commentary for PuriCore (PURI) and other London Stock Exchange equities.
Register now for FREE PuriCore share price charts
| Name | PuriCore | Epic | PURI |
|---|---|---|---|
| Activites | Food Safety accounted for 58% of fiscal 2009 revenues; Endoscopy, 41% and Other, 1% | Reuters | PURI.L |
| ISIN | GB00B3XBCR18 | Google Finance | LON:PURI |
| PURI Share Price (p) | 40.50 | Prev. Share Price (p) | 40.50 |
|---|---|---|---|
| Shares in Issue (m) | 25 | Market Cap (£m) | 12 |
| PE Ratio (x) | -1.30 | Div per share (p) | 0.00 |
| Div yield (%) | 0.00 | Div cover (x) | |
| EPS (p) | -23.10 | PEG |
Register now for FREE PuriCore company fundamentals
| Dec.Date | Type | Director | Pos | No. of Shares |
|---|---|---|---|---|
| 25/06/2012 | BUY | James Walsh | RES | 10,000 |
| 03/02/2012 | BUY | Gregory Bosch | CEO | 100,000 |
| 21/06/2010 | BUY | Darren Weiss | RES | 15,000 |
| 10/02/2009 | BUY | Gregory Bosch | CEO | 200,000 |
| 03/02/2009 | BUY | James Walsh | RES | 180,000 |
PuriCore said its first-quarter revenue plunged 23.7% to $10.9 million, with that from supermarkets down 51% to $3.6 million. Endoscopy revenue fell 4.9% to $6.2 million, whole wound care revenue rose 188.5% to $1.1 million. PuriCore is a water-based clean technology company. "We significantly...
/* */ RNS Number : 9741E PuriCore Plc 17 May 2013 PuriCore plc ("PuriCore" or the "Company") 17 May 2013 Interim Management Statement Balance sheet significantly improved PuriCore (LSE: PURI), the...
Water-based, clean technology firm PuriCore said Charles Spicer has been appointed independent non-executive director, effective June 1. It added that James Walsh has elected to step down from the board, effective from June 27. Story provided by StockMarketWire.com
Register now for FREE PuriCore company news
This one has come to my attention after a sudden surge from the bottom of its price range. In the last two weeks, PURI has announced US FDA approval to market its Sterilox Endoscopy High-Level Disinfectant System as a medical device in the US; also announced first prelims showing increasing...
Register now for FREE PuriCore share price discussions